These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24901647)

  • 61. Effects of As2O3 and Resveratrol on the Proliferation and Apoptosis of Colon Cancer Cells and the hERG-mediated Potential Mechanisms.
    Yan C; Li F; Zhang Y; Li Y; Li M; Wang F; Zhang G; Li Y; Li B; Zhao X
    Curr Pharm Des; 2019; 25(12):1385-1391. PubMed ID: 31218953
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.
    Kumagai T; Ikezoe T; Gui D; O'Kelly J; Tong XJ; Cohen FJ; Said JW; Koeffler HP
    Clin Cancer Res; 2004 Feb; 10(4):1508-20. PubMed ID: 14977855
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The sensitivity of digestive tract tumor cells to As2O3 is associated with the inherent cellular level of reactive oxygen species.
    Gao F; Yi J; Shi GY; Li H; Shi XG; Tang XM
    World J Gastroenterol; 2002 Feb; 8(1):36-9. PubMed ID: 11833067
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [In vitro effect of bortezomib alone or in combination with harringtonine or arsenic trioxide on proliferation and apoptosis of multidrug resistant leukemia cells].
    Cai YX; Meng FY; Sun QX; Fu YB; Li L
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):737-40. PubMed ID: 19176009
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells.
    Gurr JR; Bau DT; Liu F; Lynn S; Jan KY
    Mol Pharmacol; 1999 Jul; 56(1):102-9. PubMed ID: 10385689
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Attenuation of arsenic retention by resveratrol in lung of arsenic trioxide-exposed rats.
    Zhang W; Yao C; Ge M; Xue J; Ma D; Liu Y; Liu J; Zhang Z
    Environ Toxicol Pharmacol; 2013 Jul; 36(1):35-9. PubMed ID: 23545367
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.
    Lin TH; Kuo HC; Chou FP; Lu FJ
    BMC Cancer; 2008 Feb; 8():58. PubMed ID: 18294404
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Arsenic trioxide targets miR-125b in glioma cells.
    Chen S; Zhu L; Huang J; Cai Y; Lu X; Yang Q; Wu Q; Chen C; Wang Z
    Curr Pharm Des; 2014; 20(33):5354-61. PubMed ID: 24479808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cells.
    Song LL; Tu YY; Xia L; Wang WW; Wei W; Ma CM; Wen DH; Lei H; Xu HZ; Wu YL
    PLoS One; 2014; 9(8):e104985. PubMed ID: 25115845
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibitory effect of humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles conjugate on growth of human hepatocellular carcinoma: in vitro and in vivo studies.
    Yin XB; Wu LQ; Fu HQ; Huang MW; Wang K; Zhou F; Yu X; Wang KY
    Asian Pac J Trop Med; 2014 May; 7(5):337-43. PubMed ID: 25063057
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of growth of human nasopharyngeal cancer xenografts in SCID mice by arsenic trioxide.
    Li D; Du C; Lin Y; Wu M
    Tumori; 2002; 88(6):522-6. PubMed ID: 12597150
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
    Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H
    Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines.
    Lu M; Levin J; Sulpice E; Sequeira-Le Grand A; Alemany M; Caen JP; Han ZC
    Exp Hematol; 1999 May; 27(5):845-52. PubMed ID: 10340400
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei.
    Moon Y; Park G; Kim Y; Kim M; Lim J; Pai SH; Lee EJ; Kang CS; Han K
    Ann Clin Lab Sci; 2004; 34(3):271-6. PubMed ID: 15487701
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines.
    Wu Y; Xu Y; Shen Y; Wang C; Guo G; Hu T
    Braz J Med Biol Res; 2012 Mar; 45(3):187-96. PubMed ID: 22331136
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential mechanistic investigation of protective effects from imperatorin and sec-O-glucosylhamaudol against arsenic trioxide-induced cytotoxicity in vitro.
    Hu L; Sun J; Li H; Wang L; Wei Y; Wang Y; Zhu Y; Huo H; Tan Y
    Toxicol In Vitro; 2016 Dec; 37():97-105. PubMed ID: 27608960
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis.
    Ye Y; Xu X; Zhang M; Qiu D; Bai X; Wang J; Weng G; Zhou R; Guo Z; He H; Yi W; He X; Guo K
    Leuk Lymphoma; 2015; 56(11):3159-67. PubMed ID: 25739941
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of intratumoral chemotherapy using arsenic trioxide (As2O3) sustained release tablets for the treatment of neurogliocytoma in nude mice.
    Zhao HB; Sun QX; Chen XF; Han DY; Zhao SG
    Eur Rev Med Pharmacol Sci; 2014; 18(17):2453-9. PubMed ID: 25268089
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Arsenic Trioxide and Icariin Show Synergistic Anti-leukemic Activity.
    Wang Z; Zhang H; Dai L; Song T; Li P; Liu Y; Wang L
    Cell Biochem Biophys; 2015 Sep; 73(1):213-9. PubMed ID: 25721870
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A; Kizaki M; Kawamura C; Matsushita H; Fukuchi Y; Umezawa A; Yamada T; Hata J; Hozumi N; Yamato K; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2001 Aug; 15(8):1176-84. PubMed ID: 11480559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.